Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

COVID-19 vaccines used in Brazil are from ... that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

Additionally, vaccines with similar technology show that antibodies can migrate: For instance, with Moderna’s Covid-19 vaccine, antibodies are shown to move to sites of infection in the nose.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Peter Hotez has made every effort to stay up to date with Covid-19 vaccines, starting with the initial two doses and continuing through each booster iteration. “I've gotten every one possible,” he ...

More than 1,000 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

following earlier approved vaccines from Pfizer (PFE) and GSK (GSK). A health worker prepares a Moderna COVID-19 vaccine at a vaccination center. (AP Photo/K.M. Chaudary) · ASSOCIATED PRESS ...

"This agreement presents an opportunity for Moderna to support and strengthen national COVID-19 vaccination campaigns across participating countries," said Chantal Friebertshäuser, Senior Vice ...

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to ...

(Reuters) -Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines ...